Publications

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban. Rationale and Design of the Hot-Pe Trial (Vol 116, Pg 191, 2016)

AuthID
P-00M-4T8

Author(s)

Barco, S

Lankeit, M

Binder, H

Schellong, S

Christ, M

Beyer Westendorf, J

Duerschmied, D

Bauersachs, R

Empen, K

Held, M

Schwaiblmair, M

Fonseca, C

Jimenez, D

Becattini, C

Quitzau, K

Espinola Klein, C

Wild, P

Konstantinides, S

Document Type

Correction

Year published

2016

Published

in THROMBOSIS AND HAEMOSTASIS, ISSN: 0340-6245

Volume: 116, Issue: 4, Pages: 775-775 (1)

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1160/th16100001

Wos: WOS:000384964200026

Source Identifiers

ISSN: 0340-6245

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban. Rationale and Design of the Hot-Pe Trial (Vol 116, Pg 191, 2016)

Useful Links

Get Help

Federated Authentication (Click on the image)

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban. Rationale and Design of the Hot-Pe Trial (Vol 116, Pg 191, 2016)

Useful Links

Get Help